{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-071353","form_type":"8-K","ticker":"LENZ","cik":"0001815776","company_name":"LENZ Therapeutics, Inc.","filed_at":"2024-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.649943+00:00","generated_at":"2026-06-04T13:40:52.960272+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Graphite Bio stockholders approve 1:7 reverse split, name change to LENZ; effective March 21, trading as LENZ March 22","bullets":["Stockholders approved 1-for-7 reverse stock split and name change to 'LENZ Therapeutics, Inc.' at March 14 special meeting.","Reverse split and name change effective 4:01 p.m. ET March 21, 2024; no fractional shares, cash paid in lieu.","Common stock trades on split-adjusted basis under ticker 'LENZ' from March 22, 2024; new CUSIP 52635N103.","Proportional adjustments made to outstanding equity awards and shares reserved under stock plans.","Actions taken in connection with pending merger with LENZ Therapeutics; merger closing expected thereafter."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-071353","json":"https://secwatch.observer/filing/0001193125-24-071353.json","markdown":"https://secwatch.observer/filing/0001193125-24-071353.md","text":"https://secwatch.observer/filing/0001193125-24-071353.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815776/000119312524071353/0001193125-24-071353-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815776/000119312524071353/d780027d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T13:40:52.960272+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}